Blog Tag: Cell Therapy

Quarterly Protein Product Update: Spring 2019

New Proteins , Webinars and Resources

New Products

Read more about Quarterly Protein Product Update: Spring 2019

Cell and Gene Therapies for Cancer: Future Promises and Challenges

Featured speakers:

J. Joseph Melenhorst, Ph.D., University of Pennsylvania

Laurence J. N. Cooper, M.D., Ph.D., Ziopharm Oncology

Moderated by:

Sean Sanders, Ph.D., Science/AAAS

Read more about Cell and Gene Therapies for Cancer: Future Promises and Challenges

Welcome to our Summer Protein Update

New Proteins , Webinars and Resources

New Products

Read more about Welcome to our Summer Protein Update

ISSCR 2018 - Highlighting Stem Cell Therapy and 3-D Modeling

Another exciting International Society for Stem Cell Research (ISSCR) Annual Meeting has concluded

Read more about ISSCR 2018 - Highlighting Stem Cell Therapy and 3-D Modeling

Immunology News: Researchers Demonstrate the Importance of Treg Subset Selection and sLeX Expression for Human Treg Immunotherapy

Expression for Human Treg Immunotherapy

Read more about Immunology News: Researchers Demonstrate the Importance of Treg Subset Selection and sLeX Expression for Human Treg Immunotherapy

Good Manufacturing Practice (GMP) for Cell Therapy Manufacturing: What does this mean?

gmp cytokines and growth factor use in cell therapy process

Read more about Good Manufacturing Practice (GMP) for Cell Therapy Manufacturing: What does this mean?

Xeno-free, Serum-free, What’s for me? - Mesenchymal Stem Cell Media

Read more about Xeno-free, Serum-free, What’s for me? - Mesenchymal Stem Cell Media

Defining A Regulatory Path For Induced Pluripotent Stem Cells Based Cell Therapy

Kapil Bharti, PhD, National Eye Institute, Unit on Ocular Stem Cells and Translational Research

Read more about Defining A Regulatory Path For Induced Pluripotent Stem Cells Based Cell Therapy

Legal | Terms & Conditions | Privacy and Cookie Policy | Sitemap

© Copyright 2024 R&D Systems, Inc. All Rights Reserved.